While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways with more than 100 staffers at a Massachusetts facility that will pivot to ...

As GSK's vaccine ambitions grow with the launch of new respiratory syncytial virus (RSV) shot Arexvy, the company is once again investing to support its manufacturing operations. The British pharma is ...